Bioprinting Cartilage, Producing Stem Cells Fill ISS Research Schedule
On Jun. 4, 2026, 3D bioprinting and stem cell research were the main research topics aboard the International…
-
-
Lilly gains license for Ascidian’s gene-editing tech to develop kidney disease drugs worth up to $1.9 billion
On Jun. 3, 2026, Ascidian Therapeutics said it has signed a licensing deal for its gene-editing technology with…
-
Flesh-eating screwworm may have been detected in South Texas, USDA says
On Jun. 3, 2026, an infestation of the flesh-eating screwworm parasite may have been detected in South Texas,…
-
Alnylam and Inceptive Form Strategic AI Collaboration to Accelerate the Discovery of RNAi Therapeutics Worth Up to $2 Billion
On Jun. 3, 2026, Alnylam Pharmaceuticals, the leading RNAi therapeutics company, and Inceptive Nucleics, which builds foundation models…
-
Microrobots repair spinal cord
On Jun. 2, 2026, a research team from ETH Zurich and the University of Zurich (UZH) announced it…
-
Pfizer and China’s Innovent Biologics Enter Global Strategic Collaboration worth $9.85 billion to Accelerate Development of Oncology Medicines
On May 28, 2026, Pfizer and Innovent Biologics announced the companies have entered into a strategic global licensing…
-
Abbott secures CE Mark for world’s first dual glucose-ketone sensing technology for people with diabetes
On May 27, 2026, Abbott announced it has secured CE Mark for the world’s first dual glucose‑ketone sensing…
-
Lilly announces three acquisitions to build infectious disease portfolio for $3.8 Billion in Cash
On May 26, 2026, Eli Lilly announced agreements to acquire three companies, Curevo, LimmaTech Biologics, and Vaccine Company,…
-
FDA Grants Accelerated Approval to Gilead’s Hepcludex® (bulevirtide-gmod), the First and Only Approved Treatment for Chronic Hepatitis Delta Virus
On May 22, 2026, Gilead Sciences announced announced that the U.S. Food and Drug Administration (FDA) has granted…
-
Gilead Receives CHMP Positive Opinion for Trodelvy® in First-Line Metastatic Triple-Negative Breast Cancer
On May 22, 2026, Gilead Sciences announced that the Committee for Medicinal Products for Human Use (CHMP) of…
-
Engage Bio Acquired by Lilly for $202 million in cash to Accelerate Development of Non-Viral Genetic Medicines
On May 20, 2026, Engage Biologics, a preclinical biotechnology company pioneering non-viral DNA delivery, today announced that it…
-
Ebola Epidemic caused by Bundibugyo virus in the Democratic Republic of the Congo and Uganda determined a public health emergency of international concern
On May 17, 2026, the Director-General of the World Health Organization (WHO) announced that the Ebola disease caused…
-
Democratic Republic of the Congo confirms new Ebola outbreak, 80 Deaths Reported
On May 15, 2026, The World Health Organization (WHO) announced it is rapidly scaling up support to the…
-
Penny and Phil Knight’s Gift advances research into brain resilience and aging
On May 12, 2026, Stanford University announced a $90 million gift from Penny and Philip H. Knight, MBA…
-
Bristol Myers Squibb and Hengrui Pharma Announce Strategic Agreements to Advance Innovative Medicines in Deal Worth $15.2 billion
On May 12, 2026, Bristol Myers Squibb and Hengrui Pharma announced the companies have entered into global strategic…
-
Fujirebio announces CE marking of Lumipulse® G pTau 217 Plasma assay for Alzheimer’s disease
On May 11, 2026, Fujirebio Europe announced that it has obtained a CE certificate of the Lumipulse G…
-
Thousands of previously unknown proteins discovered
On May 6, 2026, a group of international researchers announced they had discovered 1,700 new proteins. The research…
-
Lilly commits additional $4.5 billion across Indiana manufacturing sites, opens first dedicated genetic medicine facility
On May 6, 2026, Eli Lilly announced an additional $4.5 billion investment across two of its three Lebanon…
-
UVA Study Reveals How New Weight-Loss Drugs Reshape the Brain
On May 6, 2026, In a study published in Nature, a team led by University of Virginia (UVA)…
-
USC launches transformational AI initiative with $200 million gift
On May 5, 2026, the University of Southern California (USC) announced a transformational initiative that will leverage AI…
-
Amgen Announces Additional $300 Million Manufacturing Investment in Juncos, PR
On May 4, 2026, Amgen announced plans to invest an additional $300 million in its U.S. manufacturing network…
-
UCB to acquire Candid Therapeutics for more Than $2 Bllion, building upon its existing immunology pipeline
On May 3, 2026, UCB, a global biopharmaceutical company, announced signing of a definitive agreement under which it…
-
Canada approves second generic semaglutide, the first G7 country to do so
On May 1, 2026, Health Canada authorized a second generic semaglutide injection. Health Canada is currently reviewing seven other…
-
Dr. Reddy’s Laboratories Announces Health Canada Approval for Generic Semaglutide Injection in Canada
On Apr. 29, 2026, Dr. Reddy’s Laboratories announced that it has received a Notice of Compliance (NOC) from…
-
Artificial Intelligence | Biotechnology | Diagnostics | Disease | Genomics | Neurology | Non-Profit Research | Oncology | Therapeutics
Biohub Launches the Virtual Biology Initiative to Galvanize a Global Effort to Create the Open Data Foundation for AI-Accelerated Biolog
On Apr. 29, 2026, Biohub announced the Virtual Biology Initiative, a landmark five-year initiative to galvanize a global…
-
UK Trials Show Paxlovid speeds recovery, but doesn’t reduce hospitalization in vaccinated patients
On Apr. 23, 2026. two national trials published in the New England Journal of Medicine report Paxlovid (nirmatrelvir-ritonavir)…
-
Biotechnology | Disease | FDA | Therapeutics
FDA Approves First-Ever Gene Therapy for Treatment of Genetic Hearing Loss
On Apr. 23, 2026, the U.S. Food and Drug Administration (FDA) approved Otarmeni (lunsotogene parvec-cwha), the first-ever dual…
-
Lilly to acquire Kelonia Therapeutics for $3.25 billion to advance in vivo CAR-T cell therapies
On Apr. 20, 2026, Eli Lilly and Kelonia Therapeutics, a clinical-stage biotechnology company pioneering in vivo gene delivery,…
-
Kailera nets $625M, biotech’s biggest-ever IPO
On Apr. 17, 2026, Kailera Therapeutics, a high-profile drug startup aiming to compete with Novo Nordisk and Eli…
-
Cancer Center at Illinois Earns Prestigious National Cancer Institute Designation
On Apr. 16, 2026, the Cancer Center at Illinois (CCIL) announced it has been designated as a Basic…
